Genmab — December 2024

[E_L]

Investor Presentation November 2024 https://ir.genmab.com/static-files/9cf9b1fd-ac9d-46ea-9834-0730621bc7be

[NiklasZ]

De sidste par dage, hvor der har været begrænset snak om Genmab i chatten, er den steget. Måske vi skulle holde radio
tavshed? :0)

[transalp]

[ProinvestorNEWS]

Knock-Your-Socks-Off-News – December 2024 https://www.linkedin.com/pulse/knock-your-socks-off-news-december-2024-genmab-zosre/

[ProinvestorNEWS]

Genmab får skåret kursmålet til 1700 kr. fra 2050 kr. af JP Morgan https://proinvestor.com/investornyt/1249692/genmab-far-skaret-kursmalet-til-1700-kr-fra-2050-kr-af-jp-morgan

[JKY_VH]

Jeg kan godt leve med en kursstigning på 10% resten af året og god morgen:-)

[Riis7]

Tænker deres kursmål er 12 mån og ikke 1 mån;-)

[JKY_VH]

Det tænker jeg også Riis:-)

[E_L]

maybe it is coincidence, but it seems JP Morgen needs to stay within a ~10% range of the current price with their targets since they started downgrading:

[E_L]

may23, target 3200 market 2880 =~11%,
dec23, target 2500 market 2200 =~14%,
aug24 target 2050 market 1850 =~11%,
dec24 target 1700 market 1551 =~10%,

[Riis7]

Maybe AI is making it;-)

[E_L]

[JKY_VH]

Ja, det ligner kunstig intelligens. Jeg foretrækker den ægte vare:-)

[bikube]

1702

[bikube]

aktier til bestyrelsen.

[E_L]

Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting / Mim8 https://www.globenewswire.com/news-release/2024/12/03/2990557/0/en/Novo-Nordisk-to-present-new-data-from-sickle-cell-disease-and-haemophilia-trials-at-the-66th-American-Society-of-Hematology-ASH-annual-meeting.html

[E_L]

the GEN1042 trial in combination with radiotherapy / pembrolizumab set to Active, not recruiting - curious if we can get some info on that soonish https://clinicaltrials.gov/study/NCT05491317

[E_L]

the last push upward went from 1515.5 to 1652 = 136.5dkk. This stint went from 1431 to 1567.5 = 136.5dkk.

[transalp]

Go morgen..

[E_L]

Scancell Announces Genmab Exercises Option to a Second Commercial License Agreement https://www.investegate.co.uk/announcement/rns/scancell-holdings--sclp/second-commercial-license-agreement-with-genmab-/8588688